STMN1 and neoplasm: We implanted parental and STMN1 knockout P3 GBM cells intracranially in immunodeficient mice that were fed a DOX diet and monitored tumor growth by daily weighing until a 8–10% loss was observed at which point animals were randomly enrolled in control or VB treatment cohorts (Fig. 5a).